Pulmonary manifestations of myeloperoxidase-antineutrophil cytoplasmic antibody(MPO-ANCA)-related systemic vasculitis:CT findings in 50 patients

Y. Ando, F. Okada, T. Maeda, Y. Kato, S. Matsumoto, H. Mori (Hasama-machi, Japan)

Source: Annual Congress 2002 - Pulmonary imaging
Session: Pulmonary imaging
Session type: Thematic Poster Session
Number: 1715
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Ando, F. Okada, T. Maeda, Y. Kato, S. Matsumoto, H. Mori (Hasama-machi, Japan). Pulmonary manifestations of myeloperoxidase-antineutrophil cytoplasmic antibody(MPO-ANCA)-related systemic vasculitis:CT findings in 50 patients. Eur Respir J 2002; 20: Suppl. 38, 1715

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease: CT and pathological findings in 62 patients
Source: Eur Respir J 2004; 24: Suppl. 48, 488s
Year: 2004

Pulmonary manifestations of systemic vasculitis in childhood
Source: Breathe, 16 (4) 200211; 10.1183/20734735.0211-2020
Year: 2020



Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease: CT findings in 149 patients
Source: Annual Congress 2012 - CT findings: educational posters
Year: 2012

Difference in chest HRCT findings in relation to ANCA subtypes in ANCA-associated vasculitis
Source: International Congress 2019 – Granulomatous disorders: from bench to bedside
Year: 2019



Radiologic finding of pulmonary vasculitis
Source: Annual Congress 2009 - Old and new: technique and pathology
Year: 2009

Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients
Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019
Year: 2020



Pulmonary vasculitis: update on the management of ANCA-associated vasculitis
Source: Eur Respir Mon; 2009: 46: 251–264
Year: 2009

Systemic manifestations of sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 95s
Year: 2006

Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020

Pulmonary and pleural manifestations in scleroderma
Source: Eur Respir J 2006; 28: Suppl. 50, 382s
Year: 2006

Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013


Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013


Thoracic manifestations of systemic autoimmune diseases: radiological findings
Source: Annual Congress 2007 - Imaging of pulmonary vascularisation and illustrated overview of lung pathology
Year: 2007


Pulmonary vasculitis
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019


Pulmonary vasculitis
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019


Pulmonary vasculitis
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018

Pulmonary vasculitis
Source: ERS Course 2016
Year: 2016



Multislice CT angiography and pulmonary involvement in asymptomatic systemic lupus patients with antiphospholipid syndrome
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011


Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005

Detection of various autoantibodies in patients with pulmonary sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019